Insmed Incorporated

NASDAQ (USD): Insmed Incorporated (INSM)

Last Price

67.99

Today's Change

+3.28 (5.06%)

Day's Change

64.79 - 68.08

Trading Volume

5,215,334

Overview

Market Cap

10 Billion

Shares Outstanding

161 Million

Avg Volume

3,227,543

Avg Price (50 Days)

36.85

Avg Price (200 Days)

29.37

PE Ratio

-13.00

EPS

-5.23

Earnings Announcement

01-Aug-2024

Previous Close

64.71

Open

65.28

Day's Range

64.7901 - 68.08

Year Range

19.68 - 68.08

Trading Volume

5,215,334

Price Change Highlight

1 Day Change

5.07%

5 Day Change

7.94%

1 Month Change

188.09%

3 Month Change

157.25%

6 Month Change

126.33%

Ytd Change

127.09%

1 Year Change

240.63%

3 Year Change

144.22%

5 Year Change

161.00%

10 Year Change

267.12%

Max Change

-58.79%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment